Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial

Clinical Therapeutics

Volumn 31, Issue 8, 2009, Pages 1765-1773

  Orlikowski, David ^a   Chevret, Sylvie ^b   Quera Salva, Maria Antonia ^a   Laforêt, Pascal ^c   Lofaso, Frédéric ^a   Verschueren, Annie ^d   Pouget, Jean ^d   Eymard, Bruno ^c   Annane, Djillali ^a  

^a Functional Exploration Department   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

excessive daytime sleepiness; modafinil; myotonic dystrophy; psychostimulants

Indexed keywords

MODAFINIL; PLACEBO;

ACNE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; DISORIENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; HYPERSOMNIA; INSOMNIA; LATENT PERIOD; MALE; MULTICENTER STUDY; MYOTONIC DYSTROPHY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISORDERS OF EXCESSIVE SOMNOLENCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; YOUNG ADULT;

EID: 72449143192     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.08.007     Document Type: Article

References (36)

1. Harper P.S. Myotonic Dystrophy (1979), Saunders, Philadelphia, Pa
2. Rubinsztein J.S., Rubinsztein D.C., Goodburn S., and Holland A.J. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 64 (1998) 510-515
3. Ono S., Kurisaki H., Sakuma A., and Nagao K. Myotonic dystrophy with alveolar hypoventilation and hypersomnia: A clini-copathological study. J Neurol Sci 128 (1995) 225-231
4. Ono S., Kanda F., Takahashi K., et al. Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus 1772 in myotonic dystrophy: A clinicopathological correlation. Acta Neuropathol 89 (1995) 122-125
5. Antonini G., Morino S., Fiorelli M., et al. Selegiline in the treatment of hypersomnolence in myotonic dystrophy: A pilot study. J Neurol Sci 147 (1997) 167-169
6. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43 (1998) 88-97
7. Kingshott R.N., Vennelle M., Coleman E.L., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 163 (2001) 918-923
8. Czeisler C.A., Walsh J.K., Roth T., et al., the US Modafinil in Shift Work Sleep Disorder Study Group. Modafinil for excessive sleepiness associated with shift-work sleep disorder [published correction appears in N Engl J Med.. 2005;353:1078]. N Engl J Med. 353 (2005) 476-486
9. Adler C.H., Caviness J.N., Hentz J.G., et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord. 18 (2003) 287-293
10. Willoughby E. Modafinil for fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry 72 (2002) 150
11. Sevy S., Rosenthal M.H., Alvir J., et al. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. J Clin Psychiatry 66 (2005) 839-843
12. Markovitz P.J., and Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antide-pressant therapy. J Clin Psychopharmacol 23 (2003) 207-209
13. Greenhill L.L., Biederman J., Boellner S.W., et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45 (2006) 503-511
14. Randall D.C., Shneerson J.M., and File S.E. Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav. 82 (2005) 133-139
15. Turner D.C., Clark L., Pomarol-Clotet E., et al. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29 (2004) 1363-1373
16. Spence S.A., Green R.D., Wilkinson I.D., and Hunter M.D. Modafinil modulates anterior cingulate function in chronic schizophrenia. Br J Psychiatry 187 (2005) 55-61
17. Scammell T.E., Estabrooke I.V., McCarthy M.T., et al. Hypothalamic arousal regions are activated during modafinilinduced wakefulness. J Neurosci 20 (2000) 8620-8628
18. van der Meché F.G., Bogaard J.M., van der Sluys J.C., et al. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 57 (1994) 626-628
19. Damian M.S., Gerlach A., Schmidt F., et al. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 56 (2001) 794-796
20. MacDonald J.R., Hill J.D., and Tarnopolsky M.A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 59 (2002) 1876-1880
21. Talbot K., Stradling J., Crosby J., and Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 13 (2003) 357-364
22. Johns M.W. A new method for measuring daytime sleepiness: The Ep-worth sleepiness scale. Sleep 14 (1991) 540-545
23. Mitler M.M., Gujavarty K.S., and Browman C.P. Maintenance of wakefulness test: A polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 53 (1982) 658-661
24. Annane D., Miller R., and Barnes P. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev. 4 (2002) CD003218
25. Richardson G.S., Carskadon M.A., Flagg W., et al. Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 45 (1978) 621-627
26. Carskadon M.A., Dement W.C., Mitler M.M., et al. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness. Sleep 9 (1986) 519-524
27. Mathieu J., De Braekeleer M., Prévost C., and Boily C. Myotonic dystrophy: Clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation [published correction appears in Neurology. 1992;42:689]. Neurology 42 (1992) 203-208
28. Walton J.N. Clinical examination of the neuromuscular system. In: Walton S.J. (Ed). Disorders of Voluntary Muscle (1981), Churchill Livingstone, New York, NY
29. Vignos Jr. P.J., and Archibald K.C. Maintenance of ambulation in childhood muscular dystrophy. J Chronic Dis 12 (1960) 273-290
30. Rechtschafen A., and Kales A. Techniques and Scoring System for Sleep Stages of Human Subjects (1968), US Government Printing Office, Washington, DC
31. Menza M.A., Kaufman K.R., and Castellanos A. Modafinil augmentation of anti-depressant treatment in depression. J Clin Psychiatry 61 (2000) 378-381
32. Mossberg K., and McFarland C. A patient-oriented health status measure in outpatient rehabilitation. Am J Phys Med Rehabil 80 (2001) 896-902
33. Gillam P.M., Heaf P.J., Kaufman L., and Lucas G.B. Respiration in dystrophia myotonica. Thorax 19 (1964) 112-120
34. Khandelwal D., Bhatia M., Tripathi M., et al. Excessive daytime sleepiness: An unusual presentation of myotonic dystrophy. Sleep Med. 3 (2002) 431-432
35. Guilleminault C., Partinen M., Quera-Salva M.A., et al. Determinants of daytime sleepiness in obstructive sleep apnea. Chest 94 (1988) 32-37
36. Laberge L., Bégin P., Dauvilliers Y., et al. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 80 (2009) 642-646